[Update: clinical lipidology]

MMW Fortschr Med. 2013 Jul 25;155(13):49-52; quiz 53-4. doi: 10.1007/s15006-013-1050-6.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Combined Modality Therapy
  • Drugs, Investigational / therapeutic use
  • Fatty Acids, Omega-3 / therapeutic use
  • Fibric Acids / adverse effects
  • Fibric Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / drug therapy
  • Hyperlipidemias / blood
  • Hyperlipidemias / drug therapy*
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / drug therapy
  • Hypolipidemic Agents / adverse effects
  • Hypolipidemic Agents / therapeutic use*
  • Lipoprotein(a) / blood
  • Reference Values
  • Risk Factors
  • Treatment Outcome
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Drugs, Investigational
  • Fatty Acids, Omega-3
  • Fibric Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Lipoprotein(a)
  • Triglycerides